Richard Kenney, MD

Trials

Studies that name Richard Kenney, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 07:51 UTC. Open this list on ClinicalTrials.gov

• Ph1
  NCT06265012 · Study to Evaluate the Recombinant VSV (rVSV)-Marburg Virus Vaccine Candidate (PHV01) in Healthy Adult Subjects

  Public Health Vaccines LLC · completed · Marburg Virus Disease · study director
• Ph1/Ph2
  NCT05435742 · SON-080 in Patients With Persistent Chemotherapy-induced Peripheral Neuropathy (CIPN)

  Sonnet BioTherapeutics · terminated · Chemotherapy-induced Peripheral Neuropathy (CIPN) · study director
• Early Ph1
  NCT05408572 · Study of SON-1010 (IL12-FHAB) in Healthy Adults

  Sonnet BioTherapeutics · completed · Healthy Adult · study director
• Ph1
  NCT05352750 · Phase 1 Study of SON-1010 in Adult Patients With Advanced Solid Tumors

  Sonnet BioTherapeutics · active not recruiting · Advanced Solid Tumor, Soft Tissue Sarcoma Adult · study director
• Ph2
  NCT02978222 · Folate Receptor Alpha Peptide Vaccine With GM-CSF Versus GM-CSF Alone in Patients With Platinum Sensitive Ovarian Cancer

  Marker Therapeutics, Inc. · terminated · Platinum Sensitive Ovarian Cancer, Ovarian Cancer · study director
• Ph2
  NCT02593227 · Folate Receptor Alpha Peptide Vaccine With GM-CSF in Patients With Triple Negative Breast Cancer

  Marker Therapeutics, Inc. · completed · Breast Cancer · study director

Grants

NIH projects from RePORTER, fetched 2026-11-12 07:51 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 1 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.